Who owns ZTS
1,552 institutions reported holding ZTS for 2026Q1, together 96% of the company, fewer than the 1,634 a quarter earlier.
1,552
Institutions reporting a position · as of 2026Q1 · down from 1,634 the quarter before
- Shares held by institutions
- 406.1M
Shares held by institutions · 96% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $48.3B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 33%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 146
- Positions exited
- 233
- Added to
- 565
- Reduced
- 580
- Top 10 holdersof the company
- 42%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 1,552 | 406.1M | $48.3B |
| 2025Q4 | 1,634 | 432.1M | $75.4B |
| 2025Q3 | 1,767 | 407.7M | $61.4B |
| 2025Q2 | 1,830 | 420.5M | $65.6B |
| 2025Q1 | 1,851 | 415.2M | $68.3B |
| 2024Q4 | 1,832 | 416.5M | $67.8B |
| 2024Q3 | 1,752 | 421.7M | $81.2B |
| 2024Q2 | 1,710 | 421.2M | $73.0B |
| 2024Q1 | 1,700 | 424.3M | $71.7B |
| 2023Q4 | 1,713 | 425.6M | $83.9B |
| 2023Q3 | 1,595 | 420.0M | $73.3B |
| 2023Q2 | 1,594 | 416.2M | $71.8B |
| 2023Q1 | 1,525 | 459.0M | $70.5B |
| 2022Q4 | 1,494 | 422.3M | $61.8B |
| 2022Q3 | 1,483 | 424.1M | $63.0B |
| 2022Q2 | 1,537 | 424.7M | $73.0B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| VANGUARD GROUP INC | 54.4M | 13% | $6.43B |
| BlackRock Inc. | 35.6M | 8.4% | $4.21B |
| STATE STREET CORP | 19.3M | 4.6% | $2.28B |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 15.9M | 3.8% | $1.88B |
| MORGAN STANLEY | 14.1M | 3.3% | $1.67B |
| GEODE CAPITAL MANAGEMENT LLC | 11.3M | 2.7% | $1.34B |
| WELLINGTON MANAGEMENT GROUP LLP | 10.2M | 2.4% | $1.20B |
| NORDEA INVESTMENT MANAGEMENT AB | 5.9M | 1.4% | $680M |
| NORTHERN TRUST CORP | 5.5M | 1.3% | $656M |
| WELLS FARGO & COMPANY/MN | 5.5M | 1.3% | $654M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - Specialty & Generic
Ranks #5 of 28 by Smart Score